GCGang Chen

Gang Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gang Chen has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Aijun Zhang

    Department of Obstetrics and Gynecology, Anhui Provincial Hospital Affiliated with Anhui Medical University, 17 Lujiang Road, Hefei, 230001, China

    1 shared publication
  • Bin Ling

    Department of Obstetrics and Gynecology, China-Japan Friendship Hospital, Beijing 100029, P.R. China

    1 shared publication
  • Cheng Peng

    Division of Life Sciences and Medicine, Department of Obstetrics and Gynecology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China

    1 shared publication
  • Chuan Chen

    Department of Obstetrics and Gynecology, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China

    1 shared publication
  • Fanglin Sun

    Department of Obstetrics and Gynecology, Anhui Provincial Hospital Affiliated with Anhui Medical University, 17 Lujiang Road, Hefei, 230001, China

    1 shared publication
  • Fengqiu Yao

    Department of Obstetrics and Gynecology, Anhui Provincial Hospital Affiliated with Anhui Medical University, 17 Lujiang Road, Hefei, 230001, China

    1 shared publication

Latest Publications

  • Open Access

    Risk factors for surgical site infections following microwave ablation of the uterus: a retrospective cohort study

    by Chuan Chen, Hanshu Wu, Xinyu Wang, Ying Peng, Ying Peng’, Lei Lei, Yangyang Zhao, Gang Chen

    As microwave ablation (MWA) becomes an increasingly popular treatment for gynecological diseases, complications such as surgical site infections (SSIs) have emerged as critical concerns, particularly in high-risk patient populations. Identifying independent risk factors for SSIs is essential to implement effective preventive measures and enhance patient outcomes. This retrospective study included women aged 18–55 with a diagnosis of uterine myoma or adenomyosis who underwent MWA at the First Affiliated Hospital of the University of Science and Technology of China between December 2020 and November 2023. Patient selection criteria included undergoing laparoscopic MWA by our team and providing written informed consent. The Kolmogorov-Smirnov test was used to assess the normality of continuous variables, and statistical analyses were performed using the Student’s t-test, Mann-Whitney U test, and χ2 test. Multivariate logistic regression identified potential predictors for SSIs. In this study, SSIs were observed in 7.58% of patients, with prolonged surgical duration and abdominal adhesions identified as significant independent risk factors. This study provides insights into SSIs following MWA surgery in a Chinese population, highlighting specific risk factors that could inform preventive strategies to improve surgical outcomes and patient safety.

  • Open Access

    Bioinformatics Analysis Identifies Molecular Markers Regulating Development and Progression of Endometriosis and Potential Therapeutic Drugs

    by Ying Peng, Cheng Peng, Zheng Fang, Gang Chen

    Endometriosis, a common disease that presents as polymorphism, invasiveness, and extensiveness, with clinical manifestations including dysmenorrhea, infertility, and menstrual abnormalities, seriously affects quality of life in women. To date, its underlying etiological mechanism of action and the associated regulatory genes remain unclear. This study aimed to identify molecular markers and elucidate mechanisms underlying the development and progression of endometriosis. Specifically, we downloaded five microarray expression datasets, namely, GSE11691, GSE23339, GSE25628, GSE7305, and GSE105764, from the Gene Expression Omnibus (GEO) database. These datasets, obtained from endometriosis tissues, alongside normal controls, were subjected to in-depth bioinformatics analysis for identification of differentially expressed genes (DEGs), followed by analysis of their function and pathways via gene ontology (GO) and KEGG pathway enrichment analyses. Moreover, we constructed a protein–protein interaction (PPI) network to explore the hub genes and modules, and then applied machine learning algorithms support vector machine-recursive feature elimination and least absolute shrinkage and selection operator (LASSO) analysis to identify key genes. Furthermore, we adopted the CIBERSORTx algorithm to estimate levels of immune cell infiltration while the connective map (CMAP) database was used to identify potential therapeutic drugs in endometriosis. As a result, a total of 423 DEGs, namely, 233 and 190 upregulated and downregulated, were identified. On the other hand, a total of 1,733 PPIs were obtained from the PPI network. The DEGs were mainly enriched in immune-related mechanisms. Furthermore, machine learning and LASSO algorithms identified three key genes, namely, apelin receptor (APLNR), C–C motif chemokine ligand 21 (CCL21), and Fc fragment of IgG receptor IIa (FCGR2A). Furthermore, 16 small molecular compounds associated with endometriosis treatment were identified, and their mechanism of action was also revealed. Taken together, the findings of this study provide new insights into the molecular factors regulating occurrence and progression of endometriosis and its underlying mechanism of action. The identified therapeutic drugs and molecular markers may have clinical significance in early diagnosis of endometriosis.